We are live on
!
Find out more
CCM
Crossvault Capital Management Portfolio holdings
AUM
$254M
1-Year Est. Return
5.07%
This Fund
S&P 500
This Quarter
Est. Return
+3.89%
1 Year Est. Return
-5.07%
3 Year Est. Return
+56.38%
5 Year Est. Return
+114.39%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$10.2M
(+5.3%)
Cap. Flow
+$3.88M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
46.67%
Holding
80
New
3
Increased
20
Reduced
22
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$3.73M |
| 2 |
Skyworks Solutions
SWKS
|
+$2.7M |
| 3 |
RTX Corp
RTX
|
+$1.57M |
| 4 |
XYZ
Block Inc
XYZ
|
+$1.57M |
| 5 |
AT&T
T
|
+$671K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$5.09M |
| 2 |
Boeing
BA
|
+$802K |
| 3 |
Visa
V
|
+$389K |
| 4 |
DuPont de Nemours
DD
|
+$360K |
| 5 |
Microsoft
MSFT
|
+$310K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.53% |
| 2 | Technology | 19.18% |
| 3 | Consumer Discretionary | 13.14% |
| 4 | Financials | 12.19% |
| 5 | Healthcare | 9.68% |
Similar funds
HA
PPW
SG
ETI
RIM
TF
TWM
IC
Crossvault Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Crossvault Capital Management held 80 positions worth $204M, up 5.3% from $194M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Crossvault Capital Management's Q2 2019 filing shows 3 new, 20 increased, 22 reduced and 3 closed positions. Its largest new stake was Skyworks Solutions: 34,025 shares worth $2.63M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.09M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Crossvault Capital Management's largest Q2 2019 buy was Skyworks Solutions: 34,025 shares worth $2.63M.
- Crossvault Capital Management added most to PepsiCo in Q2 2019, an estimated $3.73M increase.
- Crossvault Capital Management's biggest Q2 2019 reduction was Boeing, cutting an estimated $802K.
- Crossvault Capital Management fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $5.09M.
- Crossvault Capital Management's ten largest holdings make up 47% of its $204M portfolio in Q2 2019.
- Crossvault Capital Management opened 3 new positions and closed 3 in Q2 2019.
- Crossvault Capital Management's portfolio value rose 5.3% quarter-over-quarter to $204M.
Based on Crossvault Capital Management's 13F filing for Q2 2019, filed 19 Jul 2019.